NCT04927806 is a NA clinical trial of Silver Knight in Bacterial Contamination, sponsored by Fu Jen Catholic University.

Who is sponsoring NCT04927806?

NCT04927806 is sponsored by Fu Jen Catholic University.

What drugs are being tested in NCT04927806?

Interventions in NCT04927806: Silver Knight.

What condition does NCT04927806 study?

NCT04927806 studies Bacterial Contamination.

Is NCT04927806 still recruiting?

NCT04927806 is currently completed. Last updated 1 March 2023.

Last reviewed 2023-03-01 · How we verify

NCT04927806

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of Antimicrobial Breathing System on the Presence of Multidrug-resistant Organisms

Completed NA Last updated 1 March 2023

What this trial tests

NA trial testing Silver Knight in Bacterial Contamination in 24 participants. Completed in 30 June 2022.

Timeline

1 November 2021

Primary endpoint
1 June 2022

30 June 2022

Quick facts

Lead sponsor	Fu Jen Catholic University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	prevention
Enrollment	24
Start date	1 November 2021
Primary completion	1 June 2022
Estimated completion	30 June 2022
Sites	1 location across Taiwan

Drugs / interventions tested

Silver Knight

Conditions studied

Bacterial Contamination — all drugs for Bacterial Contamination →

Sponsor

Fu Jen Catholic University

Who can join

Eligibility, any sex, with Bacterial Contamination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigates the effectiveness of antimicrobial breathing system on multidrug-resistant organisms (MDRO).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Bacterial Colonization of Silver-Additive Ventilator Circuit in Patients Receiving Mechanical Ventilation: A Randomized Controlled Trial.
Chao KY, Liu WL, Chen CY, Su CH, et al · · 2025 · cited 2× · PMID 40052538 · DOI 10.1111/crj.70058

Verify or expand the search:

Other Fu Jen Catholic University trials

Trials by the same sponsor.

NCT07474220 — Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease · not yet recruiting
NCT07445035 — Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation · NA · not yet recruiting
NCT07497932 — Nutritional Effects in Cardiovascular Surgery · NA · recruiting
NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
NCT07447232 — Comparing Ultrasonic and Conventional Spirometry in Chronic Respiratory Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04927806 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fu Jen Catholic University
Last refreshed: 1 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04927806.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing